MariMed Inc. (MRMD) reported Q4 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $35.83 million versus the consensus estimate of $35.1 million.
GUIDANCE:
MariMed Inc. sees FY2023 revenue of $150+ million, versus the consensus of $152.8 million.